MyAverix Finance
F · Healthcare
Regeneron Pharmaceuticals Inc (RGO)
Biotechnology
Regeneron Pharmaceuticals Inc (RGO) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $69.20B, P/E ratio is 18.21, net margin is 31.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RGO
Regeneron Pharmaceuticals Inc (RGO) — FAQ
What is Regeneron Pharmaceuticals Inc's market cap?
Regeneron Pharmaceuticals Inc (RGO) has a reported market cap of $69.20B (data as of 2026-03-30).
What is RGO's P/E ratio?
The price-to-earnings (P/E) ratio for Regeneron Pharmaceuticals Inc (RGO) is 18.21 (data as of 2026-03-30).
Does Regeneron Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for Regeneron Pharmaceuticals Inc (RGO). Check the MyAverix Finance app for the latest dividend data.
What sector is Regeneron Pharmaceuticals Inc in?
Regeneron Pharmaceuticals Inc (RGO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RGO listed on?
RGO is listed on F.
What is Regeneron Pharmaceuticals Inc's net margin?
Regeneron Pharmaceuticals Inc (RGO) reports a net margin of 31.4% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.